Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 324,907 | 296,683 | 282,021 | 228,122 | 211,822 |
| Marketable Securities | 61,352 | 86,644 | 93,527 | 76,430 | 65,852 |
| Receivables | 133,113 | 123,330 | 107,132 | 106,836 | 95,852 |
| Inventories | 25,518 | 24,887 | 24,021 | 22,941 | 22,418 |
| TOTAL | $569,436 | $549,684 | $530,575 | $453,398 | $410,818 |
| Non-Current Assets | |||||
| PPE Net | 2,412 | 1,862 | 1,277 | 1,177 | 1,108 |
| Investments And Advances | 34,353 | 8,105 | 2,470 | 17,112 | 20,912 |
| Intangibles | 254,154 | 260,921 | 231,895 | 237,870 | 243,845 |
| Other Non-Current Assets | 30,561 | 22,241 | 18,898 | 16,268 | 13,562 |
| TOTAL | $321,480 | $293,129 | $254,540 | $272,427 | $279,427 |
| Total Assets | $890,916 | $842,813 | $785,115 | $725,825 | $690,245 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 59,399 | 9,614 | 12,167 | 17,657 | 11,639 |
| Accrued Expenses | 187,625 | 196,185 | 148,192 | 127,139 | 115,938 |
| Other current liabilities | 25,800 | N/A | N/A | N/A | N/A |
| TOTAL | $272,824 | $205,799 | $160,359 | $144,796 | $127,577 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 375,598 | 322,324 | 332,710 | 325,871 | 329,412 |
| TOTAL | $375,598 | $322,324 | $332,710 | $325,871 | $329,412 |
| Total Liabilities | $648,422 | $528,123 | $493,069 | $470,667 | $456,989 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,981 | 60,342 | 51,394 | 50,238 | 49,535 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,457,699 | -667,544 | -661,814 | -664,719 | -658,858 |
| Other shareholders' equity | -28 | 351 | 37 | 352 | -258 |
| TOTAL | $242,494 | $314,690 | $292,046 | $255,158 | $233,256 |
| Total Liabilities And Equity | $890,916 | $842,813 | $785,115 | $725,825 | $690,245 |